|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
B
|
|
INDICATIONS:
|
|
Tinea corporis |
|
Tinea cruris |
|
Tinea pedis |
|
Tinea unguium |
|
Tinea versicolor |
| |
|
|
SIDE EFFECTS:
|
|
Hypersensitivity |
|
Hepatitis |
|
neutropenia |
|
pancytopenia |
|
Stevens-Johnson syndrome |
|
toxic epidermal necrolysis |
|
Gastrointestinal disturbances |
|
Change of taste or loss of taste |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
>> Alcoholism, active |
|
>> Hepatic function impairment |
|
>> Hypersensitivity to terbinafine |
|
>> Renal function impairment |
|
|
ADULT DOSE:
|
|
Antifungal-
Onychomycosis: Oral, 250 mg (base) once a day, for six weeks (for fingernail infections) to twelve weeks (for toenail infections) .
Some toenail infections may require longer therapy, depending on the extent of the infection.
[Tinea capitis] : Oral, 250 mg (base) once a day, for four to six weeks.
[Tinea corporis]: Oral, 250 mg (base) once a day, for two to four weeks.
[Tinea cruris]: Oral, 250 mg (base) once a day, for two to four weeks.
[Tinea pedis (interdigital or plantar)]: Oral, 250 mg (base) once a day, for two to six weeks. |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Dosage has not been established. However, in one study the following doses were used in the treatment of tinea capitis in children 3 to 16 years of age -
Children 12.5 to 18.5 kg of body weight: Oral, 62.5 mg (base) once a day.
Children 18.5 to 25 kg of body weight: Oral, 125 mg (base) once a day.
Children more than 25 kg of body weight: Oral, 250 mg (base) once a day. |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|